Bridging the Treatment Access Gap: Janus Kinase Inhibitors as First-line Advanced Therapy for Inflammatory Bowel Disease in Resource-variable Settings.

Journal: Euroasian journal of hepato-gastroenterology •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Bandaranaike R, Hewitt B, Tarwater S (2026). "Bridging the Treatment Access Gap: Janus Kinase Inhibitors as First-line Advanced Therapy for Inflammatory Bowel Disease in Resource-variable Settings.". Euroasian journal of hepato-gastroenterology. https://doi.org/10.5005/jp-journals-10018-1503